retatrutide obesity triple hormone receptor agonist helps with weight loss by targeting three different metabolic pathways simultaneously.It is named also the “Triple G” because it is a hormone agonist. This triple-action approach allows it Media Centre | EASD

A double-blind placebo-controlled study of exenatide for the treatment of weight gain associated with olanzapine in overweight or obese adults with bipolar disorder, major depressive disorder, schizophrenia or schizoaffective disorder

You dont need a special GLP-1 diet. You dont need a new protocol

Exposing medication to direct sunlight UV radiation from sunlight accelerates peptide degradation significantly

cnbc.com 4KFF (January 2026)

Not ready to purchase

However, these trials concentrated on cardiovascular outcomes rather than ocular ones, with inconsistent definitions and grading, rendering them insufficient for evaluating the long-term stabilization or enhancement of retinal pathology following an acute reduction in glycosylated hemoglobin (HbA1c)